Parmax Pharma Limited (BOM:540359)
India · Delayed Price · Currency is INR 133.70
0.00 (0.00%)
At close: Nov 2, 2026
Parmax Pharma Market Cap
Parmax Pharma has a market cap or net worth of 919.71 million as of November 6, 2026. It is the 41,431st most valuable company in the world and the 3,412th biggest in India. Its market cap has increased by 615.23% in one year.
Market Cap
919.71M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#3,412 India
PE Ratio
n/a
ChartMarket Cap Chart
Since July 26, 2019, Parmax Pharma's market cap has increased from 67.90M to 919.71M, an increase of 1,254.41%. That is a compound annual growth rate of 43.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 919.71M | 626.65% |
| Dec 31, 2025 | 126.57M | -23.55% |
| Dec 31, 2024 | 165.55M | 35.86% |
| Dec 29, 2023 | 121.85M | -15.84% |
| Dec 30, 2022 | 144.79M | -35.45% |
| Dec 31, 2021 | 224.29M | 103.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Godavari Drugs | 1.21B |
| Speciality Medicines | 1.19B |
| Parnax Lab | 1.16B |
| Pharmaids Pharmaceuticals | 1.03B |
| Mercury Laboratories | 912.06M |
| Concord Drugs | 895.90M |
| Cian Healthcare | 870.75M |
| Amwill Health Care | 836.55M |